Supplemental material
Biomarkers
Volume 26, 2021 - Issue 4
Original Articles
Readily available biomarkers predict poor survival in metastatic pancreatic cancer
, 
, , , , , , , , , , , , & for the Dutch Pancreatic Cancer Group show all
Eran van Veldhuisena Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlandshttps://orcid.org/0000-0002-5664-2286View further author information
https://orcid.org/0000-0002-5664-2286View further author information, Lydia G. van der Geestb Department of Research and Development, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, The Netherlandshttps://orcid.org/0000-0003-1637-5520View further author information
https://orcid.org/0000-0003-1637-5520View further author information, , , , , , , Judith de Vos-Geelenh Department of Internal Medicine, Division of Medical Oncology, GROW – School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlandshttps://orcid.org/0000-0003-2578-1766View further author information
https://orcid.org/0000-0003-2578-1766View further author information, , , Marc G. Besselinka Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlandshttps://orcid.org/0000-0003-2650-9350View further author information
https://orcid.org/0000-0003-2650-9350View further author information, Hanneke W. van Laarhoveni Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The NetherlandsCorrespondence[email protected]
https://orcid.org/0000-0003-3546-9709View further author information
https://orcid.org/0000-0003-3546-9709View further author information & for the Dutch Pancreatic Cancer Group show all